# A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension

> **NCT01028651** · — · COMPLETED · sponsor: **United Therapeutics** · enrollment: 13 (actual)

## Conditions studied

- Portopulmonary Hypertension
- Pulmonary Arterial Hypertension
- Pulmonary Hypertension

## Interventions

- **DRUG:** Treprostinil

## Key facts

- **NCT ID:** NCT01028651
- **Lead sponsor:** United Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2017-02-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01028651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01028651, "A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01028651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*